News Releases News Releases HOME HOME



October 19, 2000

Product Release: Semper QT, Quick Dissolving Motion Sickness Tablets




Taisho Pharmaceutical Co., Ltd. (President: Akira Uehara), announces the October 30 release of Semper QT, a tablet-form motion sickness remedy that - using Zydis technology - dissolves almost instantly. Semper QT is the first motion sickness product in Japan to incorporate this technology.

Thanks to the quick dissolving Zydis technology, Semper QT can be taken without water or chewing. The tablets take much less time to dissolve than previously available "chewable" medicines, providing quick and easy relief of motion sickness - even if nausea has already begun. R.P. Scherer, Inc. holds a worldwide patent on this technology, which goes under the name "Zydis" when used in the manufacturing of medical products. The technology is manufactured using a novel freeze-drying technique, such as that used for food products, and has been most successful in the production of quick-dissolving tablets. We first began experimenting with Zydis technology in 1996, and, with the introduction of Semper QT, employ the technology in an OTC product for the first time ever in Japan.

Product Features
(1) Zydis technology enables Semper QT to be taken without water or chewing.
(2) One tablet weighs only 0.02g, and can be easily taken, even when motion sickness has already begun.
(3) Pleasant fruity flavor


Product Overview
Product Name Semper QT
Contents and Price 6 tablets, 1000 yen (excluding tax)
Composition
(one tablet)
d-maleic acid chlorpheniramine: 2mg
Hidrobromic acid scopolamine: 0.25mg
Aspartame (L-phenylalanine compound) and scents are added.
Use For relief and prevention of dizziness, nausea and headaches resulting from motion sickness.
Dosage Place the appropriate amount in the mouth to dissolve.
To prevent motion sickness, take one tablet 30 minutes prior to boarding.
Take additional one-tablet doses, as required, at intervals greater than four hours.
Age Adults (15 years and older) Children under 15 years of age
Dosage Size one tablet Not to used
Frequency no more than twice daily
Release Date October 30, 2000
Sales Goal for
the First Year
400 million yen (on shipment basis)